Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Total Operating Expense: ₺185.6 Mil (TTM As of Mar. 2026)


IST:ONCSM Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
80 GF Score
Price ₺252.00
GF Value ₺252.15
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Operating Expense?

Oncosem Onkolojik Sistemlernayi ve Ticaret AS IST:ONCSM +0.40% 80 Total Operating Expense is ₺185.6 Mil as of Mar. 2026. GuruFocus rates IST:ONCSM with a GF Score™ of 80/100 and a GF Value™ of ₺252.15 (Fairly Valued). The stock has 4 warning signs investors should review.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense for the three months ended in Mar. 2026 was ₺74.6 Mil. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was ₺185.6 Mil.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Operating Expense Related Terms

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Operating Expense Chart

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial 16.67 65.44 133.66 168.89 160.05

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Quarterly Data
Dec19 Dec20 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 53.03 37.12 42.63 31.34 74.55
IST:ONCSM
80GF Score
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS IST:ONCSM
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₺185.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of ₺185.6 Mil mean?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) has a Total Operating Expense of ₺185.6 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense too high?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Total Operating Expense is ₺185.6 Mil. Overall, Oncosem Onkolojik Sistemlernayi ve Ticaret AS has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense compare to ABT and SYK?
Oncosem Onkolojik Sistemlernayi ve Ticaret AS's Total Operating Expense of ₺185.6 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Oncosem Onkolojik Sistemlernayi ve Ticaret AS and its competitors. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's current Total Operating Expense is ₺185.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) is currently considered Fairly Valued. The stock's GF Value™ is ₺252.15, compared to a current price of ₺252.00 — trading 0.1% below its estimated fair value. The current Total Operating Expense is ₺185.6 Mil. Oncosem Onkolojik Sistemlernayi ve Ticaret AS's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM), the current Total Operating Expense is ₺185.6 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Oncosem Onkolojik Sistemlernayi ve Ticaret AS (IST:ONCSM) Overvalued in 2026?

Based on GuruFocus' analysis, Oncosem Onkolojik Sistemlernayi ve Ticaret AS stock appears to be undervalued. The current stock price of ₺252.00 is trading 0.1% below its estimated GF Value™ of ₺252.15. GuruFocus considers Oncosem Onkolojik Sistemlernayi ve Ticaret AS to be Fairly Valued.

Key valuation signals for IST:ONCSM:

  • Total Operating Expense: ₺185.6 Mil
  • GF Value™: ₺252.15 vs. price of ₺252.00 (0.1% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the IST:ONCSM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Oncosem Onkolojik Sistemlernayi ve Ticaret AS Business Description

Address Mutlukent Mah. 1988 Cad. No: 12, Cankaya, Ankara, TUR
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is specialized in the production of equipment and medical devices used in cancer treatment.
80GF Score

Get the complete analysis for IST:ONCSM

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺252.00
Price
₺252.15
GF Value